Urogen Pharma Drug Patent Portfolio
Urogen Pharma owns 1 orange book drug protected by 2 US patents Given below is the list of Urogen Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9040074 | Material and method for treating internal cavities | 20 Jan, 2031 | Active |
| US9950069 | Material and method for treating internal cavities | 20 Jan, 2031 | Active |
Latest Legal Activities on Urogen Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Urogen Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 17 Nov, 2022 | US9040074 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 13 Oct, 2021 | US9950069 |
| Post Issue Communication - Certificate of Correction | 24 Jun, 2019 | US9040074 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Nov, 2018 | US9040074 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Apr, 2018 | US9950069 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Apr, 2018 | US9950069 |
|
Email Notification
Critical
| 05 Apr, 2018 | US9950069 |
|
Issue Notification Mailed
Critical
| 04 Apr, 2018 | US9950069 |
|
Application Is Considered Ready for Issue
Critical
| 19 Mar, 2018 | US9950069 |
| Dispatch to FDC | 19 Mar, 2018 | US9950069 |
|
Issue Fee Payment Received
Critical
| 16 Mar, 2018 | US9950069 |
|
Issue Fee Payment Verified
Critical
| 16 Mar, 2018 | US9950069 |
| Supplemental Papers - Oath or Declaration | 26 Feb, 2018 | US9950069 |
|
Email Notification
Critical
| 01 Feb, 2018 | US9950069 |
|
Electronic Review
Critical
| 01 Feb, 2018 | US9950069 |
Urogen Pharma's Family Patents
Urogen Pharma Drug List
Given below is the complete list of Urogen Pharma's drugs and the patents protecting them.
1. Jelmyto
Jelmyto is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9040074 | Material and method for treating internal cavities |
20 Jan, 2031
(5 years from now)
| Active |
| US9950069 | Material and method for treating internal cavities |
20 Jan, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jelmyto's drug page